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T
his special issue of the Biosafety Protocol News coincides 
with the preparations for the midterm evaluation of the 
Strategic Plan for the Cartagena Protocol on Biosafety, 
in conjunction with the third assessment and review of the 
Protocol, scheduled to be conducted at the eighth meeting of the 
Conference of the Parties serving as the meeting of the Parties to 
the Cartagena Protocol on Biosafety (COP-MOP 8)1. Accordingly, the 
title of the issue is “Progress in Implementing the Strategic Plan for 
the Cartagena Protocol (2011-2020)”.
The newsletter contains articles from all of the geographical regions 
of the United Nations and two organizations. Topics cover various 
aspects of implementation of the Protocol, in particular with respect 
to the operational objectives of the Strategic Plan. These issues 
include: National Biosafety Frameworks, risk assessment and risk 
management, handling, transport, packaging and identification, 
liability and redress, socio-economic considerations, unintentional 
transboundary movements, information sharing and the Biosafety 
Clearing-House (BCH), communication and outreach, including 
public awareness, education and participation and compliance 
with the Protocol.
This issue of the newsletter provides an in-depth review of the 
progress made and challenges encountered. Since the adoption 
of the Protocol in January 2000, many Parties have taken the 
necessary steps towards establishing legal, administrative, and 
other measures to implement their obligations under the Protocol. 
A comparative analysis of the second and third national reports on 
the implementation of the Protocol has indicated gradual progress. 
Further to the information provided in the national reports, the 
authors of the various articles elaborate more on their experiences 
and lessons learned. They also provide key recommendations that 
can assist stakeholders in their preparations leading up to COP-
MOP 8.
Most contributors indicate that the development and 
implementation of legal frameworks is key to implementation 
of the Protocol. They also note the positive results that capacity-
building projects make to biosafety systems (e.g. training materials, 
case studies, etc.)
Articles from Eastern Europe, Asia, and Africa provide valuable 
lessons on developing systems for communication, public 
awareness, education and participation, including access to 
information. The articles from Asia and the Global Industry 
Coalition (GIC) also provide experiences on the development and 
management of valuable national biosafety registries/clearing-
houses as well as the Central Portal of the BCH.
1 The Strategic Plan is available at: http://bch.cbd.int/protocol/issues/cpb_stplan_txt.shtml
Articles from Latin America and Eastern Europe also discuss 
experiences regarding the implementation of the Nagoya-
Kuala Lumpur Supplementary Protocol on Liability and Redress 
under the Protocol. These include the development of national 
administrative and legal instruments in order to have in place 
necessary response measures for potential damage to biodiversity 
caused by living modified organisms (LMOs).
An article from Western Europe highlights the importance of 
developing conceptual clarity on socio-economic considerations 
and to promote a better understanding of socio-economic 
considerations.
Three articles from West Asia, Africa and Easter Europe report 
on progress regarding handling, transport, packaging, and 
identification of LMOs, including the unintentional transboundary 
movement.
Articles from Asia, Africa and the GIC highlight work on risk 
assessment of LMOs under the Protocol, including training, 
consensus-building, developing guidance, and information sharing.
 
All contributors outline challenges regarding the slow 
implementation of biosafety systems. Lack of financial, technical, 
and institutional capacities are also highlighted. In addressing these 
challenges, there is recognition of the need to integrate biosafety 
into existing national, regional, and international environmental 
and sustainable development initiatives. In essence, biosafety 
needs to be better promoted as an environmental and sustainable 
development issue.
I would like to take this opportunity to thank all of the contribu-
tors to this issue of the newsletter. We need to enhance the 
implementation of the Protocol by minimizing the challenges 
that impede our activities. I urge Parties that have not submitted 
the third national report to do so as soon as possible. I also urge 
all Parties that have not yet done so to ratify the Supplementary 
Protocol prior to COP-MOP 8 to ensure its coming into force.
Introduction 
by Braulio Ferreira de Souza Dias    
Executive Secretary, Convention on Biological Diversity
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I
n Norway, prior to the deliberate release of living 
modified organisms (LMOs), thorough scientific as-
sessments of health and environmental effects must 
be carried out. In addition, the Norwegian authorities 
also assess socio-economic impacts, ethics, and whether 
the production and use of a given LMO may contribute to 
sustainable development. By establishing such a broad 
assessment approach, our aim is to contribute to the con-
servation and sustainable use of biodiversity. At the same 
time, our goal is to arrive at decisions that serve the com-
mon good and meet our societal needs.
In 2001, Norway was the third country to ratify the 
Cartagena Protocol on Biosafety.  Under Article 26, 
Parties to the Protocol may consider socio-economic 
considerations when reaching national decisions 
regarding the authorization of LMOs. For Norway, 
through the Norwegian Gene Technology Act , the socio-
economic dimension was already an integral part of LMO 
assessments in 1993. 
The Norwegian Gene Technology Act
In line with other international and national LMO 
regulations, issues related to environmental or health 
risks are of paramount importance within the Norwegian 
regulatory framework for LMOs. In addition to health and 
environmental safety, the Norwegian Gene Technology Act 
has provisions regarding sustainability, benefits to society, 
and ethics in the spirit of the Brundtland Commission’s 
report: Our common future (1987) . Sustainability is a 
complex term that, in the Norwegian legislation, has 
been ascribed quite a broad meaning. Assessments of 
sustainability should be global and ideally cover longer 
periods, even generations. Along with social consequences 
and economic issues, the impacts on biodiversity is an 
important element of sustainability. In the Norwegian 
Act, “Benefit to society” is primarily linked to the societal 
benefits and disadvantages within our national borders. 
With its LMO regulation, Norway’s aim is to encourage 
responsible innovation, reflect on global and long-term 
effects, and to contribute to sustainable development.
The provisions on the socio-economic criteria in the 
Gene Technology Act are present in the preamble, in 
Article 10 relating to approval, and in appendix four of 
the Regulations relating to impact assessment pursuant 
to the Gene Technology Act . This appendix contains, for 
example, checklists with socio-economic (and ethics/
sustainability related) considerations that can be asked 
when assessing a given LMO. The Norwegian Parliament 
has recognized that applications on biotechnology may 
have profound effects on society. That is why the Act 
sets out that socio-economic considerations must be 
assessed prior to an approval. At the same time, neither 
the Act itself, nor its legislative history, provides any clear 
guidance as to how the socio-economic dimension is to be 
understood. However, it is clear that the assessment does 
not focus on the benefits to the manufacturer or applicant. 
Moreover, it goes beyond the consumers or direct users. It 
is also a matter of third-party considerations and whether 
people become affected on a broader scale, for instance 
by changes in employment opportunities.
The Norwegian Biotechnology Advisory Board
The Norwegian Biotechnology Advisory Board is a key 
player in Norway for socio-economic considerations in 
the context of LMOs. The Board is an independent body 
consisting of 15 members appointed by the Norwegian 
government. The composition of the board reflects that 
complex social issues preferably are not only discussed 
by experts. This is why various stakeholders and non-
professionals are also board members who bring diverse 
and valuable perspectives to the table. 
The Board has a mandate to evaluate the social and 
ethical consequences of modern biotechnology and to 
discuss usage that promotes sustainable development. 
The Board is mentioned in the Gene Technology Act 
and has contributed substantially to the national 
operationalization of the Act . When assessing an LMO, 
the Board has developed an approach which asks rel-
evant questions. Through this exercise, favourable or 
unfavourable social consequences may be disclosed. 
Socio-Economic Considerations 
under the Protocol: Experiences and 
Lessons Learned from Western Europe
NORWAY 
by Vidar Helgesen   Minister of the Ministry of Climate and Environment. 
He can be reached at: postmottak@kld.dep.no
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Part of the checklist structure for socio-economic impacts is 
as follows:
1. Characteristics of the product
Is it reasonable to say that there is a demand or a need for 
the product?
Is it reasonable to say that the product will solve or help to 
solve a social problem?
Is it reasonable to say that the product is significantly better 
than similar products that are already on the market?
Is it reasonable to say that there are alternatives that are more 
suitable than this product for solving or helping to solve the 
social problem in question?
2. Production and use of the product
Will the product have a positive effect on industrial devel-
opment and wealth creation, including new employment 
opportunities?
Will the product have a positive effect on industrial develop-
ment and wealth creation, including new employment oppor-
tunities, in rural areas in particular?
Will the product have a positive effect on industrial develop-
ment and wealth creation, including new employment oppor-
tunities, in other countries?
Will the product tend to create problems for existing produc-
tion that should be maintained? 
Will the product tend to create problems for existing produc-
tion in other countries?
An evaluation of the socio-economic impacts of an LMO, and 
whether it is of benefit to society, is based on a discussion of 
the answers to the relevant questions asked. Note that the 
above-mentioned list is not exhaustive. On the other hand, 
some questions may be irrelevant for a particular case. 
National decisions
To date, socio-economic considerations have not been given 
decisive weight in Norwegian decisions regarding LMOs for 
the market. Norway has decided to prohibit the deliberate 
release of several LMOs based on a combination of arguments, 
being both linked to health and environmental issues and 
related to sustainability and socio-economic considerations. 
A “mixed bag of arguments” was also the case for the 
assessment which lead to approvals of genetically modified 
carnations. For such LMOs, sustainability effects and socio-
economic considerations did not outweigh the fact that the 
environmental risk was negligible and that health risk was 
absent.
Challenges
The lack of relevant data is a challenge for Norway when 
assessing LMOs and socio-economic impacts . That is 
why Norwegian authorities regularly request additional 
information from applicants. Furthermore, data may be 
non-conclusive or merely indicative of a possible effect. The 
Norwegian Environment Agency is currently cooperating with 
the Norwegian Biotechnology Advisory Board in order to de-
velop more trait-specific guidelines for assessment of sustain-
ability and benefit to society. This work may lead to a clearer 
and more focused approach in the Norwegian assessment of 
socio-economic impacts of LMOs. 
Two recent reports from the Norwegian Biotechnology Advisory 
Board may also serve as a basis for further development of the 
framework. One report is on herbicide resistant genetically 
modified plants and sustainability  and the other is on insect 
resistant genetically modified plants and sustainability . These 
reports include more comprehensive lists of parameters that 
may be relevant to a deeper assessment of sustainability 
issues. Also, GenØk, the centre for biosafety in Norway, has 
published reports on the operationalization of the criteria for 
sustainability, social utility, and ethics. For example, there is an 
examination of the social and ethical issues raised by possible 
cultivation of genetically modified potato with late blight re-
sistance in Norway . 
Further work under the Protocol
With reference to the Strategic Plan of the Cartagena Protocol, 
Norway and other Parties are committed, by the year 2020, to 
develop guidelines regarding socio-economic considerations. 
Once available, guidance should be applied by Parties, as 
appropriate. This work is highly welcomed by the Norwegian 
government. It is in line with our national Gene Technology Act 
and may guide us to a better operationalization of our own 
national Act. This is also why Norway supported and co-chaired 
a workshop on socio-economic considerations in India in 2011 
and is contributing financially to the current Ad Hoc Technical 
Expert Group (AHTEG) on Socio-Economic Considerations.
Recommendations
Today’s knowledge base is uneven with major differences 
across countries and regions. There is also significant variation 
in the capacity to use data, information, and knowledge in 
policy development and decision-making. Together, we must 
try to fill these gaps. Let us ensure that modern biotechnology 
is utilized for the common good and is a useful tool for the 
conservation and sustainable use of biological diversity! 
The Biotechnology Advisory Board evaluates 
the social impacts of modern biotechnology and 
LMOs contribution to sustainable development 
MARCELO QUINI/UNSPLASH/ TROMSØ, NORWAY
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National Legislation, its Implementation and Enforcement
L
egislation is a basis for the successful implementation of 
international obligations. The safe use of genetically modi-
fied organisms (GMOs) in the Czech Republic is regulated 
by Act 78/2004 on the Use of Genetically Modified Organisms and 
Genetic Products. The Act covers LMOs for contained use, deliber-
ate release into the environment and placing on the market. Since 
its entry into force in February 2004, it has been amended several 
times and in line with developments at the global (the Cartagena 
Protocol on Biosafety) and regional (the European Union) level. 
The last amendment was adopted by the Czech Government 
in December 2015 and the process of approval in Parliament is 
ongoing. This amendment transposes the EU Directive 2015/412 
enabling member countries to restrict or impose a ban on plant-
ing of GMOs on their territory. As a member country, some EU 
Regulations are directly applicable in the Czech Republic (espe-
cially those related to food and feed, including labelling). To Act 
78/2004 there is a corresponding Decree 209/2004, on Detailed 
Conditions for the Use of GMOs and Genetic Products, which is 
amended on an ongoing basis to be in line with the Act. Due to 
the diverse use of GMOs, relevant national legislation, including 
that of other sectors, needs to be respected and kept in line with 
developments in biosafety requirements.
The Ministry of Environment is the Competent National Authority 
and plays a crucial role in the implementation of legislation by 
handling notifications and regulating the use of GMOs. It does so 
in close cooperation with the Ministry of Agriculture (e.g. rules of 
coexistence, GM food and feed) and the Ministry of Health (e.g. 
risks to human health). The Czech Commission for the Use of GMOs 
and Genetic Products was established on the basis of the Act as an 
expert advisory body of the Ministry of Environment. It consists of 
scientists, representatives of administrative authorities and spe-
cialized organizations, including non-governmental organizations 
(NGOs). The Commission assists in the assessment of notifications, 
consultation on draft policy and legislative documents, consulta-
tions on non-compliance or remedial measures, in methodology 
of sampling and detection, and provides information on new sci-
entific developments and emerging issues.
With regards to enforcement, the Czech Environmental 
Inspectorate represents the main authority and closely cooper-
ates with several other authorized supervisory bodies. 
Nagoya-Kuala Lumpur Supplementary Protocol on 
Liability and Redress
The Czech Republic ratified the Nagoya-Kuala Lumpur 
Supplementary Protocol on Liability and Redress to the Protocol 
in February 2012. The ratification was based on existing national 
legislation – namely, (1) Act 167/2008 on Prevention of Ecological 
Damage and its Remedies, (2) Regulation of the Government 
295/2011 on the Way of Risk Assessment of Environmental Damage 
and Detailed Conditions of Financial Security, and (3) the basic Act 
89/2012 – Civil Code. At the European level, Directive 2004/35/EC, 
on Environmental Liability with Regards to the Prevention and 
Remedying of Environmental Damage, is applicable.
Information sharing and submission of data to BCH
The legislation of the Czech Republic covers the right of its citi-
zens to information through the Act on Free Access to Information 
and the special Act on the Right to Environmental Information. 
Specifically, in the field of genetic modification, the Act on the Use 
of Genetically Modified Organisms and Genetic Products applies.
The list of authorized users, decisions, relevant legislation and 
other important  information regarding the use of GMOs is made 
available to the public and updated on the website of the Ministry 
of the Environment (www.mzp.cz) in Czech. Through the Ministry 
website and official bullitin boards of relevant regional authori-
ties, the public is consulted during the authorisation process of 
field trials. Information regarding coexistence, food and feed is 
available at the Ministry of Agriculture website (www.eagri.cz). 
All relevant information is also submitted in the national BCH 
Portal (http://www.mzp.cz/biosafety) in English alongside both 
mandatory information required under Article 20 of the Cartagena 
Protocol and other optional information which is important at 
the national level (e.g. national guidelines, reference materials 
or publications). Certain information is available in the EU BCH 
to which the Czech national BCH provides a link.
Compliance and Review under the 
Protocol: Experiences and 
Lessons Learned from 
Central and Eastern Europe 
THE CZECH REPUBLIC  
by Milena Roudna   Advisor at the Ministry of Environment.
She can be reached at: milena.roudna@seznam.cz
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Communication, Education and Public Awareness 
Communication is a prerequisite for the successful imple-
mentation of adopted legislation and regulatory measures. 
Communication needs to be developed at different levels, includ-
ing among authorities, among decision-makers and experts, and 
with the public. Each of these levels require corresponding forms 
which respect national conditions. 
In the Czech Republic, the Commission for the Use of GMOs and 
Genetic Products plays an important role in this respect. It en-
ables discussion among representatives of authorities and insti-
tutions which are concerned with the use of GMOs. With regards 
to the public, an annual meeting is open to the public and is fo-
cused on key issues under the Protocol.
 
Education on biotechnology and biosafety is reflected in the cur-
ricula of Czech universities and special educational programmes. 
Elementary and secondary schools teaches these issues only in a 
broader context. Through their programmes, certain centres of 
environmental education contribute to the knowledge of teach-
ers and children.
Public awareness can be enhanced in various ways, such as 
through media, publications and leaflets, meetings and work-
shops. From the Czech experience, cooperation proved to be very 
useful. The Czech Republic cooperates with the following: 
• Professionals and civil society, NGOs, Local governments
• Nature conservation organizations and institutions
• Centres for environmental education Museums and similar 
institutions
Support to Other Countries in Capacity Building
The Czech Republic has offered assistance on biosafety issues 
to other countries in the Balkans, Eastern Europe, and Central 
Asia. This bilateral assistance was offered on the basis of the re-
quirements of other countries (e.g. in Macedonia). It was regional 
in the form of training workshops held in cooperation with the 
Food and Agriculture Organization and within national coordi-
nation between the Ministry of Agriculture and the Ministry of 
the Environment. Both forms were positively evaluated and the 
continuation of regional training workshops was recommended.
Conclusion and Recommendations
The mission of the Strategic Plan for the Cartagena Protocol can 
only be achieved if appropriate measures are taken at the na-
tional level. Corresponding legislation is a basic step for further 
activities which should be followed up by implementation and 
enforcement measures. 
Communication and cooperation among responsible authorities 
and implementing institutions is a prerequisite to a functioning 
biosafety system and successful implementation. Access to infor-
mation and the sharing of information, as well as public aware-
ness and education, play an important role of the Cartagena 
Protocol. Education in the field of biotechnology and biosafety 
can be incorporated into broader environmental education 
which can lead to greater support. Cooperation with universities, 
schools, centres of environmental education, civil societies and 
NGOs will attract broader audiences. Workshops, public events, 
and publications made available in the language of target groups 
are recommended ways of knowledge sharing. 
Asistance to less advanced countries will enhance the implemen-
tation of the Strategic Plan at the regional and global level. 
The meetings of the Commission for the 
Use of GMOs and Genetic Products are 
open to the public once a year
SUCHÉ SKÁLY KOBEROVY/ UNSPLASH/CZECH REPUBLIC MILENA ROUNDNA/REGIONAL TRAINING WORKSHOP ON BIOSAFETY ISSUES FOR THE COUNTRIES 
OF EASTERN EUROPE AND   CENTAL ASIA ORGANIZED IN COOPERATION WITH FAO, CZECH REPUBLIC
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Overview
M
exico, like many other Parties to the Cartagena 
Protocol on Biosafety, has fully implemented domes-
tic biosafety regulations but has made no significant 
progress on the issue of liability and redress under the Nagoya-
Kuala Lumpur Supplementary Protocol on Liability and Redress 
to the Cartagena Protocol. For example, the implementation of 
domestic legislation, in compliance with the Cartagena Protocol, 
is operational while, on the other hand, the liability regulations 
are limited to comply with the minimum regulatory standards 
and response measures to address any ‘environmental’ or ‘bio-
diversity’ damage resulting from the use of LMOs. 
Moreover, the ratification of the Supplementary Protocol faces 
some challenges:  whether a Party or not, there is no interna-
tional consensus on an ad-hoc definition of adverse effects on 
the conservation and sustainable use of biological diversity in 
this context (and these possible effects have not materialized 
yet). Therefore, in some other countries, where the full imple-
mentation of the Cartagena Protocol is a priority, the liability and 
redress issue is not considered with similar urgency.
 
Context
The Strategic Plan for the Cartagena Protocol includes topics, 
which the Conference of the Parties serving as the meeting of 
the Parties to the Cartagena Protocol (COP-MOP) may consider 
at its eight meeting, such as “To review the need for any guid-
ance or assistance to Parties in their efforts to establish and ap-
ply the Supplementary Protocol and/or and national rules and 
procedures on liability and redress related to living modified 
organisms (LMOs)”1. 
Moreover, at COP-MOP7, one of the topics on the agenda was to 
raise awareness about the aims of the Supplementary Protocol 
in order to expedite its entry into force and encourage organiza-
tions to work towards the development of an explanatory guide 
on the Supplementary Protocol2. The latter reflects the fact that 
Parties are in need of guidance and capacity-building on liability 
and redress for biodiversity damage caused by LMOs.
Mexico signed the Supplementary Protocol on March 12, 2012 and 
ratified it on September 26, 20123. Moreover, in its Third National 
Report on the Implementation of the Cartagena Protocol , Mexico 
provides the details and activities it has undertaken to imple-
ment the Supplementary Protocol. The following table reflects 
this information:
1 Decision BS-V/16 Strategic plan for the Cartagena Protocol on Biosafety for the 
period 2011-2020 Annex II Programme of Work of The Conference of The Parties 
Serving as the Meeting of the Parties to the Cartagena Protocol on Biosafety For The 
Period 2012 2016, 2.3 (d)
2 Decision Adopted by the Conference of the Parties serving as the Meeting of the 
Parties to the Cartagena Protocol on
Biosafety, BS-VII/11. Nagoya – Kuala Lumpur Supplementary Protocol on Liability 
and Redress, Seventh meeting Pyeongchang, Republic of Korea, 29 September - 3 
October 2014 UNEP/CBD/BS/COP-MOP/DEC/VII/11, para. 6,4, October, 2014
3 Third National Report on the implementation of the Cartagena Protocol on Bio-
safety, Record ID 109148, México
2015-11-02.
The Nagoya-Kuala Lumpur Supplementary 
Protocol on Liability and Redress to the 
Protocol: Experiences from Latin America
MEXICO
by Claudia Colmenarez Ortiz    Ph.D. candidate at the Department of European, 
Public and International Law, Faculty of Law at Gent University in Belgium and Independent 
Researcher for the Inter-ministerial Commission for Biosafety of GMOs. She can be reached at: 
Claudia.ColmenarezOrtiz@UGent.be
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Mexico addresses damage to biodiversity in the Law on 
Biosafety of Genetically Modified Organisms (LBOGM) 
which specifically addresses, in Article 121 para. 1, civil 
liability for damage against persons and goods for GMO-
related activities under the terms of federal civil legisla-
tion.  In addition, under the same article, the LBOGM deals 
with environmental damage by providing that there is an 
assumption the misuse or mishandling of GMOs causes 
damage to the environment or biological diversity. 
Moreover, the provisions laid down in Article 203 of 
the General Law for the Ecological Equilibrium and the 
Protection of the Environment establish the obligation to 
compensate in conformity with applicable civil legislation. 
Finally, administrative sanctions will be implemented 
corresponding to acts or omissions which constitute 
infractions of this law in cases when these infractions 
constitute environmental crimes in accordance with the 
applicable provision in the Federal Penal Code1.
Even though damage to biodiversity is addressed in 
Mexican legislation, capacity building measures should 
be implemented in order to properly define and evalu-
ate damage. In particular, the Parties require, within the 
international approach, more guidance on implementing 
domestic law.
Conclusion 
As explained above, capacity-building needs and priorities 
in the context of liability and redress have been partially 
addressed. The Supplementary Protocol also provides the 
basic elements to support the Parties in the implementa-
tion process. However, more assistance is needed in order 
to establish rules and procedures that address damage. 
Recommendations
In particular, the concept of damage and the definitions 
in the Supplementary Protocol should be discussed in 
further detail in compliance with the objectives of the 
Convention and the Cartagena Protocol. This should be 
done prior to addressing the operational provisions of the 
Supplementary Protocol.
1 LBOGM Article 121 para. 7, Federal Penal Code Artícle 420 Ter.
Mexico has administrative and legal instruments 
that provide for response measures for damage to 
biodiversity resulting from LMOs
DAMIKO/ISTOCKPHOTO/BIODIVERSITY
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Unintentional Transboundary Movements 
of LMOs: Experiences from 
Central and Eastern Europe
SLOVAKIA
N
ature has no borders so life, including living 
modified organisms (LMOs) may spread across 
national boundaries. It forces the proponents 
of LMOs to have appropriate guidelines that extensively 
address the issue of the transboundary movement of 
LMOs. Cooperation with neighbouring countries on en-
vironmental issues is correspondingly important.
The Slovak Republic is a small, land-locked country in the 
heart of Europe. There are several strong reasons for it 
to play an active role in cooperation on environmental 
issues, particularly with neighbouring countries: Slovakia 
is at the intersection of important ecosystems and there-
fore a host to rich biodiversity. Two Slovak sites, regis-
tered on the United Nations Educational, Scientific and 
Cultural Organization (UNESCO) list of world cultural and 
natural heritage sites, are transboundary nature sites. 
The deliberate release of LMOs or an accidental release 
(e.g. from a facility handling LMOs for contained use) 
may, in certain circumstances, give rise to an uninten-
tional transboundary movement of LMOs. Accordingly, 
the Slovak legal system stipulates detailed rules on how 
to prevent or minimize the risks associated with such 
movements.
Only genetically modified organisms (GMOs) or genetic 
products authorised for placing on the market in the 
European Union (EU) may be imported or exported to 
and from the Slovak Republic. Furthermore, the entity 
responsible for LMOs for contained use may import or 
export GMOs if they are covered by the authorisation pro-
vided that they are exclusively intended for contained 
use. On the other hand, the entitiy authorised to import 
or export GMOs for other purposes than placing on the 
market is obliged to have the consent of the Ministry of 
Environment. Transboundary movements within the EU 
are considered neither as exports nor imports. However, 
such transport must be described in the notification for 
LMOs for contained use or deliberate releases of LMOs 
for other purposes than placing on the market, as appro-
priate (e.g. packaging, means of transport, emergency 
measures, etc.)
The authorisation recipient is obliged to ensure that no 
genetically modified material derived from field trials is 
placed on the market or causes an unintentional trans-
boundary movement. 
The isolation distance from the nearest field is not pre-
scribed in the legislation. This is because it is crop-specific 
and therefore the distance is set on a case-by-case basis 
of individual authorisations. Genetically modified plants 
are usually destroyed at the trial site with the exception 
of samples that are taken for further analyses and are 
then destroyed afterwards. Handling of genetically modi-
fied material and waste management, as well as storage 
and means of transport, must be described in detail in 
the notification dossier. 
Every entity that handles genetically modified seeds, cul-
tivates plants or analyses them after harvesting must 
be authorised. From 2007–2013, the only experimentally 
grown genetically modified plant was maize with the 
exception of one sugar beet. 
After its commercial release, a genetically modified 
plants may be grown on very large areas. However, the co-
existence control and legal and precautionary measures 
concerning GM and non-GM agricultural crops in Slovakia 
are in force to avoid the unintended presence of GMOs 
in conventional and organic crops. The only transgenic 
crop currently authorized for commercial cultivation and 
grown in Slovakia is MON810 corn.
Since the first year of genetically modified crop culti-
vation in 2007, the coexistence concept in the Slovak 
Republic is obligatory for every farmer growing geneti-
cally modified crops. Nevertheless, from 2006–2011, small 
GM admixtures (the mean contamination level 0,07%) in 
harvested crops from neighbouring non-GM maize fields 
were observed. The contamination was caused due to a 
combination of factors such as contamination by sowing 
machines, harvesting machines, transport and storage. 
The appropriate corrective measures were applied1. 
1 Horváth, L. Horecká, T., Feketová, M. (2012) Cultivation of Biotech Crops, Control 
by Miroslava Feketova, Tatiana Horecka and Natalia Mogelska    Dr. Horecka is the Head of thenspection unit for Biosafety at the Slovak Environmental Inspectorate. She can be contacted at tatiana.horecka@siz
Feketova, Head of the Department of Molecular Biology at the Central Control and Testing Institute of 
Agriculture. She can be reached at: miroslava.feketova@uksup.sk . Mogelska, National Focal Point for the 
Protocol. She can be reached at: natalia.mogelska@enviro.gov.sk. Horecka, Head of the Inspection Unit for 
Biosafety at the Slovak Environmental Inspectorate. She can be reached at: tatiana.horecka@sizp.sk .
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The inspection of GM fields and neighbouring conventional 
maize fields (including field characteristics such as distances, 
areas, flowering synchronicity and prevailing winds) and the 
sampling of harvested crops are conducted by the inspectors 
of the Central Control and Testing Institute of Agriculture 
(CCTIA). The Department of Molecular Biology (DMB) of the 
CCTIA is a reference laboratory for the control of coexistence. 
It is responsible for the detection, identification, quantifica-
tion, and evaluation of LMO admixtures in harvested crops 
in non-GM fields. The DMB is a member of the Biosafety 
Clearing House Network of Laboratories for the Detection and 
Identification of LMOs. It is also is a member of the European 
Network of GMO laboratories (ENGL). 
The main executive body on environmental policy is the Slovak 
Environmental Inspectorate (SEI) with countrywide responsi-
bility for environmental compliance assurances, including en-
forcement of the Cartagena Protocol. Its responsibilities also 
concern trade in endangered species (under the Convention on 
International Trade in Endangered Species (CITES)) and access 
to genetic resources (under the Nagoya Protocol on Access 
to Genetic Resources and the Fair and Equitable Sharing of 
Benefits Arising from their Utilization (ABS)). In this respect, 
cooperation between inspectors is an asset and, in a broader 
sense, information sharing is considered an integral part of 
the regulation. In cooperation with customs authorities, the 
SEI performs controls on transboundary movements of waste, 
dangerous chemicals and pesticides, endangered species, and 
LMOs. 
The few events of illegal use of LMOs (e.g. zebra danios, rat, 
flax, soybean, and maize) occurred because the user had not 
recognized that the organisms were genetically modified. The 
sources of the illegal LMOs were discovered within the EU and 
therefore the cases have been dealt with in conformity with 
EU regulations. These measures taken were intended to stop 
the use the LMOs. Note, however, that this was done because 
the LMOs were illegal at the time and not because of the iden-
tification of any adverse effects.
of Co-existence and Environmental Monitoring of GM Plants in Slovakia, Plant Protect. Sci. 
Vol. 48.
The year 2016 marks the 15th year of Slovak biosafety regula-
tion at the national level. The data gathered through inspec-
tions verified the effectiveness of isolation distances, techni-
cal rules, and production practices and support the conclusion 
that the state authorities are not aware of any serious illegal 
use of LMOs in the Slovak Republic, including unintentional 
transboundary movement.
Recommendations 
The cooperation of inspectors from various institutions han-
dling LMOs is an asset and the information sharing must be 
considered as an integral part of regulation in a broader sense. 
Communication at a personal level as well as the opportunity 
to compare and verify the experiences of control activities in 
international workshops is very valuable and in Europe pos-
sible due to the network for GMO inspectors and inspector-
ates – the European Enforcement Project on Contained Use 
and Deliberate Release of GMOs (EEP). We consider regional 
networks with the aim to exchange experiences on method-
ologies for inspection and enforcement very useful. 
There is also one recommendation for the users of LMOs. They 
should not be afraid to contact the authorities for clarification 
in case of doubt as this feedback helps to improve the activity 
of authorities in the field of public awareness.
Coexistence controls as well as legal and 
precautionary measures concerning GM and 
non-GM agricultural crops are in force to avoid 
the unintended presence of GMOs in 
conventional and organic crops
JOHAN FOXX/THINKSTOCK
/ 12 BIOSAFETY PROTOCOL NEWS   /  APRIL 2016
SPECIAL ISSUE: PROGRESS IN IMPLEMENTING THE STRATEGIC PLAN FOR THE CARTAGENA PROTOCOL ON BIOSAFETY (2011-2020)
T
he Cartagena Protocol on Biosafety, ratified by 
Tunisia in 2002 , is an important instrument that 
ensures the safe transfer, handling and use of liv-
ing modified organisms, commonly known as genetically 
modified organisms (GMOs)1.
Being aware of the impact of rapidly expanding modern 
biotechnology on the economy and the environment, 
Tunisia was engaged in the process of developing a na-
tional biosafety framework (NBF). As a result, a number 
of initiatives took place as follows:
• The establishment of any institutes, schools, 
research centres and laboratories specializing in 
biotechnology; 
• The agriculture, health, environment and industry 
sectors developed biotechnological approaches;
• The establishment of a National Gene Bank; 
• The establishment of a permanent commission on 
GMOs; and 
• Biosafety reflected in national interests 
From 2007 to 2015, Tunisia took part in the United Nations 
Environment Programme – Global Environment Facility 
(UNEP-GEF) Project to support implementation of the 
NBF in Tunisia. The main objectives of the project were 
as follows:
• Integration of biosafety in the a national development 
strategy;
• Establishment and consolidation of a fully functional and re-
sponsive regulatory regime in line with other international 
obligations;
• Preparation of specific training guides and manuals on risk 
assessment of LMOs;
1 The Cartagena Protocol on Biosafety is an additional agreeement to the United 
Nations Convention on Biological Diversity. It was adopted in Montreal, 29 January 
2000 and entered into force on 11 September 2003. It entered into force for Tunisia 
11 September 2003.
• Enhancement of the existing institutional facilities and in-
frastructures to undertake GMO detection and monitoring 
activities;
• Establishment of a mechanism for enforcement monitor-
ing; and
• The promotion of public awareness and participation under 
the Protocol.
With regards to the national biosafety strategy, national 
consultative meetings were held to identify elements for 
strategic biosafety activities and to prepare and review 
the implementation of the Protocol. 
The National Legal Framework on Biosafety
The first legal framework was drafted in 2001. It contains 
two draft laws on as follows:
• The use, import, transit, and deliberate release of 
GMOs; and
• The direct use of GMOs for food or feed.
In 2005, the Ministry of Environment opted for one draft 
law for GMOs for contained use, GMOs for direct use for 
food or feed, transit of GMOs, and the deliberate release 
of GMOs. 
However, up until 2009, no national consensus was 
reached between national departments in the Tunisian 
government. After meetings of the National Biosafety 
Committee (NBC), a draft law on GMO and GMO products 
was reviewed and adopted in Tunisia.
In 2011, after the Tunisian revolution, a new context 
emerged. By 2014, there was a better understanding of 
biosafety and biotechnology issues and the national 
technical biosafety commission drafted a new version of 
the law on biosafety that integrates the issues of patho-
gens and invasive alien species.
Compliance and Review under the Protocol: 
Experiences and Lessons Learned from 
Northern Africa
TUNISIA
by Kaouthar Tlichealou    Executive Manager of the Agency of Protection and Land use Coastal Areas.  
She can be reached at: kaouthar_tliche@yahoo.fr
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In 2015, the government dedicated time to examine the drafts 
on invasive alien species and the related issue regarding li-
ability and redress under the Protocol. Also, in 2014, a decree 
to create a National Authority on Biosafety was drafted. The 
objective of the National Authority on biosafety include:
• Coordinating of the National Network Laboratories for GMO de-
tection and quantification;
• Maintaining the National Register of GMOs and their products 
approved at the national level;
• Amending the list of modern biotechnology techniques and meth-
ods for genetic modification and updating it on a regular basis;
• Preparing and updating the list of national experts in the field of 
biosafety in accordance with the requirements of the Protocol; 
and
• Facilitating the exchange of scientific, technical, environmental, 
and legal expertise in the field of biosafety.
Monitoring and Enforcement
The competent national authorities in the Ministry of 
Environment in Tunisia (DGEQV) prepared methodologies and 
procedures for monitoring, inspection, and enforcement as 
follows:
• In 2012, three agreements were signed regarding capacity build-
ing that concerned a network of national laboratories for GMO 
detection and quantification, a central laboratory for analysis, a 
technical center of food analysis, and a laboratory of seeds at the 
Ministry of Agriculture. 
• Stakeholders benefitted from overseas training which improved 
their expertise in investigating GMOs.
• Most of the equipment and laboratory items, e.g. biology mo-
lecular items (e.g. a GMO detection and quantification kit), was 
purchased for the national laboratories network for GMOs after 
having signed the conventions (the gene bank, the central labora-
tory for analysis, the technical center for food analysis, and the 
laboratory of seeds at the Ministry of Agriculture). 
Training
Over the last years, there was also a number of capacity-build-
ing training initiatives as follows:
• Series of training sessions and practical activities on sampling, 
detection and identification of GMO’s organised in 2014 .
• The signing of the Network Laboratories Commission: an agree-
ment for the implementation of the national Laboratories 
Network (GMO detection and quantification) in 2015 . This includes 
a biotechnology research center (e.g. Centre de Biotechnologie de 
Sfax (CBS)) for members of the network to contribute to scientific 
monitoring of GMOs. 
Public awareness, education and participation
Regarding public awareness, education and participation un-
der the Protocol, a number of activities took place over the 
recent years. From 2014 to2015, several meetings on public 
awareness were organized with the participation of nongov-
ernmental organizations and other stakeholders, including 
the media . There was also an interactive CD-ROM on GMO’s 
disseminated at different national events with a translated 
designed publication of technical guides. 
Over the years, a strategy and action plan on biosafety was 
also developed. n 2014, a commission on communication and 
public awareness was established. One of the tasks is the 
preparation of an action plan regarding communication on 
biosafety soon to be adopted.
Recommendations
To implement the biosafety legal framework and strategy, the 
main lessons learned experience is that Tunisian authorities 
should:
• Integrate biotechnology development and biosafety processes 
in the general national plan of development;
• Review national policies, laws, and regulations in the related sec-
tors for subsequent implementation of the biosafety framework, 
particularly on control procedures and risk assessment;
• Develop a consultative approach to familiarize different stake-
holders with the contents of the biosafety framework;
• Develop the national Biosafety Clearing-House;
• Ensure technical training on important issues under the Protocol, 
particularly on risk assessment and GMO detection;
• Facilitate the accessibility of biosafety information and elabo-
rate on a national strategy for public awareness, education and 
participation under the Protocol;
• Encourage studies and research on biotechnology and biosafety; 
and
• Enhance coordination between the public and private institutions 
and other stakeholders on biosafety processes.
 
A commission on biosafety communication 
and public awareness prepared 
an action plan
THINKSTOCK
/ 14 BIOSAFETY PROTOCOL NEWS   /  APRIL 2016
SPECIAL ISSUE: PROGRESS IN IMPLEMENTING THE STRATEGIC PLAN FOR THE CARTAGENA PROTOCOL ON BIOSAFETY (2011-2020)
V
ietnam became a party to the Cartagena Protocol 
on Biosafety in 2004. Since then, Vietnam has been 
obliged to comply with and implement all of the 
provisions of the Protocol.
To implement the Protocol, as well as to promote devel-
opment and safe use of biotechnology in our country, 
the Government of Vietnam has issued a set of policies 
and regulations on biosafety. Up until now, a biosafety 
framework has been put in place. The Ministry of Natural 
Resources and Environment (MONRE) and the National 
Focal Point for the Cartagena Protocol on Biosafety have 
actively participated in the Central Portal of the Biosafety 
Clearing-House (BCH) which was established under Article 
20 of the Protocol. 
Thanks to the United Nations Environment Program 
(UNEP) and the Global Environment Facility (GEF), Vietnam 
took part in the first BCH project as well as add-on proj-
ects of the development and implementation of the na-
tional biosafety framework. Besides the establishment 
and operation of a national BCH, MONRE has formulated 
regulations to enable the operation of the national BCH 
and the participation of Viet Nam in the Central Portal of 
the BCH. It also raised awareness by carrying out a series 
of nation-wide training and outreach activities.
The creation of a legal environment to enable the opera-
tion of the national BCH and information-sharing mecha-
nism on biosafety.
  The information-sharing mechanism on biosafety and 
the public role in decision-making are key elements under 
the Protocol and detailed regulations are stipulated in the 
following legal documents:
- The Law on Biodiversity (2008) provides articles on pub-
lishing information on potential risks to biodiversity from 
genetically modified organisms (GMOs), genetic speci-
mens of GMOs and corresponding management measures 
(Article 67).
- Decree No. 69/2010/ NĐ-CP, dated 21 June 2010, of the 
Government on biosafety management of GMOs, genetic 
specimens, and products of GMOs. It regulates: Labeling 
goods containing GMOs, GMO products; Security of in-
formation about GMOs; Disclosure of information about 
GMOs with respect to the environment, biodiversity, hu-
man and animal health; and Management of a database 
on GMOs. For example, with regards to disclosure of in-
formation, in the decision-making process for Certificates 
of Biosafety, in order for a Certificate must issued for a 
GMO to be used as food/animal feed, a risk assessment 
summary must be published on the website for public 
comments 30 days prior.
- Circular No. 09/2012/TT-BTNMT, dated 22 August 2012, 
from the Minister of Natural Resources and Environment 
on the provision and exchange of information and data on 
GMOs. This Circular provides specific provisions on figures, 
information and databases on GMOs, the development 
and management of a database on GMOs, and the posting, 
provision, exploitation and use of information.
These initatives give mandates to different organizations 
regarding the proper sharing of information on biosafety.
Operating the National BCH and making use of the Central 
Portal of the BCH for sharing and using information
Since 2006, the MONRE has acted as the National Focal 
Point and has directed the development and operation of 
national BCH (www.antoansinhhoc.vn). The National BCH 
provides the following information:
- The system of biosafety management agencies;
- Procedures for granting licenses,certificates orconfirma-
tion letters;
-  Public comments on risk assessments of GMOs;
- A list of GMOs granted licenses of, for example, assays, 
certificates of biosafety,or confirmation of being qualified 
to be used as food and feed;
- Domestic and international news; and
- References for biosafety including, for example, a net-
work of experts on biosafety, materials, publications, 
conferences, workshops.
Outreach and Information Sharing 
under the Protocol: Experiences 
and Lessons Learned from Asia 
VIETNAM 
by Hoang thi Thanh Nhan  Biosafety Clearing-House Focal Point and 
Emergency Measures Contact Point. She can be reached at: hoangnhan.bca1@gmail.com
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In accordance with the Protocol, the national focal point 
for the BCH also provides updated information on biosafe-
ty on the Central Portal of the BCH. Within the country, the 
MONRE has engaged competent national authorities in or-
der to provide information. They have been trained on how 
to participate in the national BCH and the Central Portal.
Vietnam’s authorities also make use of information avail-
able in the Central Portal of the BCH, during the decision-
making process on GMOs, such as information on risk as-
sessments, decisions on the intentional release of GMOs 
into the environment or using them for food, feed and 
processing.
Outreach and information sharing 
Since 2006, the MONRE has been collaborating with other 
ministries and international organizations to conduct 
various workshops and training in order to enhance ca-
pacity and awareness for various stakeholders, including 
management of staff and researchers at the central and 
local levels. 
Information on biosafety is also widely published through 
mass media. 
Other outreach materials that are helping to improve bio-
safety awareness were also developed and distributed. 
They include, for example, frequently asked questions 
about GMOs and pocket books on fundamental knowl-
edge about biosafety.
Conclusion and recommendations
It has been more than ten years since Vietnam became a 
Party to the Cartagena Protocol and it has made signifi-
cant efforts to fulfil its obligations as a Party. Vietnam 
has been prompt in providing updated information on 
biosafety in the Central Portal of the BCH. It has also con-
ducted many other activities to share information and 
raise public awareness on biosafety. Furthermore, it has 
benefited from the information available in the Central 
Portal of the BCH for GMO management within the coun-
try. Current public awareness of biosafety issues has sig-
nificantly increased.
 So far, the Central Portal of the BCH has been operating 
efficiently and is a good tool for information sharing and 
learning among Parties and other stakeholders. This has 
been a good experience for other working thematic areas 
to draw upon, such as the Nagoya Protocol on Access to 
Genetic Resources and the Fair and Equitable Sharing of 
Benefits Arising from their Utilization.
In order to implement the protocol on biosafety effective-
ly, we would recommend the Secretariat to continue facili-
tating the information-sharing mechanism on biosafety, 
using the current BCH to share best practices as a model 
for managing GMOs, providing  outreach services of the 
Protocol to enhance relevant national and international 
stakeholders by making available on the BCH outreach ma-
terials on biosafety, providing training on outreach skills, 
as well as increasing understanding of the relationship 
between the Protocol and the Convention on Biological 
Diversity and other biosafety-related agreements.
Vietnam has benefited from 
the information available in 
the Central Portal of the BCH regarding 
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T
he Cartagena Protocol on Biosafety (CPB) was 
adopted in January 2000 and came into force on 
11 September 2003. Since then, Parties in the west 
Asian countries have been assessing their biosafety 
systems and capacities while paving the way for the 
application of the required biosafety procedures for the 
Protocol’s implementation. Putting in place national or 
regional biosafety systems, and strengthening existing 
capacities, are at the heart of effective implementation. 
Biosafety systems include risk assessment and risk 
management (Articles 15 and 16), information sharing 
(Article 20), and handling administrative procedures 
regarding the transfer and use of genetically modified 
organisms (GMOs) (Articles 7, 11, and 18). Strengthening 
existing capacities includes scientific and technical 
training in biosafety management and the use of risk 
assessment and biosafety management. In Article 22 of 
the Protocol, Parties “shall cooperate in the development 
and/or strengthening of institutional and individual 
capacities on biosafety and biotechnology for the 
purpose of the effective implementation of the protocol.”
To date, all west Asian countries (namely Bahrain, Iraq, 
Jordan, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, 
Syria, and Yemen) have signed the Protocol. Since their 
ratification in 2003, countries in the region have been 
active in mobilizing efforts to develop national policies 
and laws for the implementation of the Protocol. 
Especially in Jordan, Lebanon, Syria, and Yemen, this 
was assisted by participating in the first cluster of 
the United Nations Environment Programme – the 
Global Environment Facility (UNEP-GEF) projects on 
the development of National Biosafety Frameworks 
(NBFs) and the countries national Biosafety Clearing-
House (nBCH). However, in those countries, laws are 
still lacking, which are guidelines and effective tools 
for the implementation of the Protocol. Gaps remain at 
the administrative level where there is a need to foster 
cooperation between the national authorities involved 
in biosafety management. After 2010, countries in the 
Persian Gulf have recorded further achievements in 
preparation for the implementation of the Protocol. For 
example, in 2014 the Sultanate of Oman developed its 
NBF and law, the United Arab Emirates (UAE) recently 
initiated a series of activities aimed at the development 
of its NBF with related implementation tools, and Saudi 
Arabia and Qatar adopted temporary measures while 
awaiting the development of biosafety laws and other 
national tools for the implementation of the Protocol. 
The NBFs of the west Asian countries have sought sound 
national policies which focus on: 
(1) Promotion of sound and orderly research and 
development in the field of modern biotechnology; 
(2) Minimization of the risks likely to be caused by 
products of modern biotechnology to ensure the 
protection of human health, biodiversity and the 
environment; and 
(3) Regulation of the transboundary movement of the 
products resulting from modern biotechnology by 
establishing relevant policies, governance structure, and 
regulatory systems . 
Parties are anticipating capacity-building programmes 
and systems to operationalize the implementation of 
their biosafety laws and NBFs.  
Biosafety systems have been advancing at a slow pace. 
Few Parties in the region have developed their nBCH. 
Although Jordan, Lebanon, and Syria launched their nBCH 
(under either the UNEP-GEF NBF project or Biosafety 
Clearing-House I project), national nodes are still in great 
need of information and records indicative of the degree 
of effective implementation of the Protocol in the region. 
At another level, advances in handling procedures in 
countries stemmed from reliance on existing regulatory 
measures and standards. Also, in Kuwait, Oman and UAE, 
there are accredited laboratories and food safety laws 
on the labeling and detection of GMOs which define 
the range of acceptance. In Lebanon, the UNEP-GEF NBF 
project mobilized efforts to define a nationally accredited 
laboratory for GMO detection. In this context, through a 
Master of Science thesis on GMO detection in imported 
Food and Feed for Processing (FFPs) an accredited 
laboratory at the American University of Technology 
and Science (AUST) was used to set up protocols for 
the detection of GMOs. Post-graduate research studies 
From Capacity Building to Biosafety 
Systems under the Protocol : Experiences 
and Lessons Learned from West Asia
THE UNITED NATIONS ENVIRONMENT PROGRAMME (UNEP) IN LEBANON
by	 Elsa Sattout   UNEP Consultant on the CBD, CPB and ABS Protocol. 
She can be reached at: e.j.sattout@gmail.com
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have contributed to strengthening technical capacity 
in applied biotechnology research. Additionally, a 
regional project, undertaken by the Food and Agriculture 
Organization (FAO) between 2011 and 2013, targeted 
the Northern Arabian Peninsula and upgraded existing 
systems on GMO detection and improved existing 
tools. This paved the way for Risk Assessment and Risk 
Management (RARM). However, there is still a lot to 
implement in the field of RARM throughout the region.
The first cluster of UNEP-GEF projects on NBF initiated a 
series of activities that raised awareness on the CPB and 
biosafety. Capacity-building needs have been assessed 
and plans for related programs have been integrated in 
the NBFs of Parties including in Lebanon, Syria, Jordan, 
and Oman. While mechanisms for RARM have been 
put in place in Jordan, training activities on RARM are 
few. Only one training activity was reported in each 
of these countries: Bahrain, Iraq, Lebanon, Oman, and 
UAE. Therefore, national strategies and detailed action 
plans are still needed in order for government agencies 
and academic/research institutions to strengthen their 
systemic, institutional, and technical capacities in the 
field. 
Diversity of scientific communities in the region is at 
the heart of advancement in biotechnology. However, 
there is still a need for astrong foundation of an enabling 
environment to integrate biosafety practices in the 
existing regional networks (e.g. at www.plantgenetic.
com) and to develop inclusive national and regional 
plans which combine practices in biotechnology 
with biosafety management. While countries have 
been striving to strengthen technical capacity in 
biotechnology and to execute research projects/studies, 
they are still lacking the long-term vision for a framed 
research agenda integrating RARM capacity building 
and better operationalization of the nBCH. Regional 
networks that have been established over the past few 
years remain  having minor interactive information and 
lack the strong leadership required to fill in the existing 
gaps in regulatory measures related to biosafety. The 
perpetual evolution of the science of biotechnology 
and the slow pace of advancement in biosafety are 
keeping Parties in the region behind what is needed to 
move forward. At present, the Regional Plant Genetic 
Resources Knowledge and Innovation Network Platform 
for Near East and North Africa is comprised of nine 
countries. This virtual platform gathers professionals 
and practitioners working on plant genetic resources 
related to sustainable agriculture and food security. 
The existing network provides a space for information 
sharing between the institutions in the member 
countries and plays a leading role in boosting efforts for 
the effective implementation of the Protocol.
Recommendations
The challenges in implementing the Protocol still weigh 
on government officials in west Asian countries. On top 
of the overwhelming agenda, with few allocated officials, 
and instability in the region, the availability of funds 
dedicated to the implementation of the Protocol hinders 
advancement in some countries. On another general 
note, there is a sense that climate change has taken over 
the GEF budgeting agenda for countries. It is crucial that 
Parties maintain momentum with strong leadership to 
improve the governance aspect, communication, and 
technical implications of the implementation of the 
Protocol. It could be that only a spoonful of guidelines 
on how to boost the Protocol and its implementation 
is what is needed in the west Asian countries! These 
could stem from a regional initiative undertaken by 
existing centers and institutions. The existing regional 
institutions and networks, either those independent 
or affiliated to universities and governments, can play 
a major role in encouraging the adoption of a culture 
supportive of biosafety in labs and elsewhere. 
The Regional Plant Genetic Resources 
Knowledge and Innovation Network 
Platform for Near East and North Africa 
is a platform for professionals of plant 
genetic resources. It facilitates information 
sharing between the institutions in the 
member countries and plays a leading 
role in boosting efforts for the effective 
implementation of the Protocol.
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T
he Biosafety Clearing-House (BCH) was established 
under Article 20 of the Cartagena Protocol on 
Biosafety (Biosafety Protocol) as a primary 
mechanism to facilitate the exchange of biosafety 
information related to living modified organisms (LMOs). 
At their second meeting, Parties to the Biosafety Protocol 
initiated a process aimed at compiling information, 
submissions, and expert inputs on experiences related 
to implementing Article 15 (risk assessment) and Article 
16 (risk management) of the Biosafety Protocol in order 
to support national implementation efforts by Parties in 
these areas.
Since that time, the Global Industry Coalition (GIC) has 
compiled and submitted information on risk assessment 
and risk management, as well as on a number of other 
topics, through the BCH1.  Additionally, the GIC has 
actively been engaged in multiple fora including online 
and face-to-face meetings of the Ad Hoc Technical Expert 
Group on Risk Assessment and Risk Management (AHTEGs) 
and the discussion groups of the Open-ended Online 
Expert Forum on Risk Assessment and Risk Management 
(Online Forum).  Our goal has been to share best practices 
and state-of-the-art, science-based information on risk 
assessment and risk management to support the work of 
the Secretariat in assisting Parties in the implementation 
of Article 15 and 16.  
Below are brief reflections and recommendations on the 
ongoing process to develop guidance on risk assessment 
and risk management as mandated by Parties at every 
Conference of the Parties serving as the meeting of the 
Parties (COP-MOP) since its fourth meeting in 2008.  
We are currently witnessing experts debating over widely 
divergent ideas on risk assessment of LMOs under the 
Biosafety Protocol.  Experiences among the participating 
experts varies widely, from academic involvement and 
critical analysis to the real-world experiences of writing, 
1 The GIC receives input and direction from trade associations representing 
thousands of companies from all over the world.  Participants include associations 
representing and companies engaged in a variety of industrial sectors such as plant 
science, seeds, agricultural biotechnology, food production, animal agriculture, hu-
man and animal health care, and the environment.
submitting and conducting risk assessments for, and 
by, regulatory authorities.  Over the years, numerous 
versions of the non-binding guidance (“the Guidance 
on Risk Assessment of LMOs”) and training materials 
have been drafted and “tested” multiple times without 
achieving consensus (most recently by 43 Parties, 3 non-
Parties, and 10 organizations (see:
http://bch.cbd.int/protocol/testing_guidance_RA.shtml). 
After the last meeting of the AHTEG in Brasilia, in 
November 2015, several difficult but significant issues 
remained unresolved and they have been sidelined for 
the time-being.  However, time to resolve these issues is 
short since the results of these efforts will be considered 
at the next COP-MOP in December 2016 in Cancun, Mexico. 
In the face of highly divergent views of the Guidance, 
the Secretariat and the Chair have worked very hard to 
find an agreement.  As mentioned, efforts to improve 
the Guidance took the form of multiple rounds of 
“testing” by Parties and other stakeholders.  In addition, 
smaller sub-working groups have been tasked to resolve 
or accommodate many challenging elements of the 
Guidance.  If bringing the roadmap to some definitive 
endpoint was not challenging enough, recent mandates 
from Parties have been interpreted as calling for 
additional work. This includes the development of further 
guidance materials on special topics (listed below), 
prioritization of more topics for guidance (listed below), 
as well as a mechanism to annotate guidance documents 
with relevant references into documents and develop 
training materials based on the (as yet uncompleted) 
guidance:  
Proposed Further Guidance:  (a) risk assessment of living 
modified plants with stacked genes for traits; (b) risk 
assessment of living modified plants with tolerance to 
abiotic stress; (c) risk assessment of living modified trees; 
(d) post-release monitoring and long-term effects of LMOs 
released into the environment; and (e) risk assessment of 
living modified mosquitoes.  
Proposed Topics for Guidance:  (a) risk assessment 
of living modified trees; (b) risk assessment of living 
Risk Assessment under the Protocol: 
Experiences and Lessons Learned 
from Industry
THE GLOBAL INDUSTRY COALITION  
by Thomas E. Nickson   Chair of the Global Industry Coalition Risk Assessment Workgroup. 
He can be reached at: thomas.nickson@monsanto.com
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modified fish; (c) risk assessment of living modified 
microorganisms and viruses; and (d) risk assessment and 
risk management in specific receiving environments.  
The AHTEG continues to work through a combination 
of online and face-to-face exchanges to address 
the challenging issues that remain in the Guidance 
Document.  After first achieving consensus, perhaps the 
second greatest challenge this AHTEG will face will be 
to complete the job of resolving and/or accommodating 
the numerous and disparate comments and suggestions 
received as a result of the testing.  Efforts are again being 
made to create a process to manage this challenge.  
Nevertheless, the question remains whether it is possible 
for all of the contradictory suggestions to be reconciled 
and if, in the end, guidance will be produced that is useful 
and grounded in real-world experiences.  
The GIC will continue to support national implementation 
of the Biosafety Protocol, including Articles 15 and 16. 
Our engagement in implementation through discussions 
on risk assessment and risk management has focused 
on sharing our years of experiences in this area. We 
also draw upon information from others with relevant 
experiences.  We have engaged in these fora with the 
intention of supporting outcomes and work products 
that provide maximum value to the largest number of 
Parties under the Biosafety Protocol.  
Recommendations
The GIC recommends that:
- Parties recognize the importance of sharing experiences 
in conducting risk assessments that formed the basis 
of their decision-making, particularly by those Parties 
and other government with extensive experience in 
this area.  With this information, the AHTEG can ensure 
that any guidance developed accurately reflects these 
experiences.  Furthermore, focus should be placed 
on developing foundational guidance that reflects 
a consensus among experts. If this can be achieved 
then the need for additional guidance can be better 
determined and subsequently developed.  
- Guidance developed through the expert processes 
must accurately reflect and clearly communicate how 
risk assessment has been used in decision-making.  In 
this way, a final guidance will serve the needs of Parties 
for information to implement, based on real-world 
experiences, Article 15 and 16.
The GIC looks forward to continuing the work on these 
important articles in the lead-up to the next COP-MOP in 
December 2016.
ALEX AHOI/UNSLASH/SCHUPPEN 52, HAMBURG, DEUTSCHLAND
GIC’s engagement in implementation of the Protocol was through sharing 
years of experiences and information on risk assessment and risk management of LMOs
SEIYA KAWAMOTO;/THINKSTOCK
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Useful Information
SECTION II /  USEFUL INFORMATION 
E-learning Modules
• Access to Information 
• Public Participation
Soon available at the CBD website
Annual Exhibition at 
the Redpath Museum, 
McGill University, Montreal
May 2015 
Highlighting: 
The UN Decade on Biodiversity and the 
International Day of Biodiversity 
4000 visitors
Fair at COP-MOP 7
Presentation: 
The Republic of Korea
https://www.cbd.int/mop7/cepafair/default.shtml
893 Likes, please join us at https://www.facebook.com/UN.Biosafety
 Online Discussions
• Discussion groups on public participation regarding 
LMOs
• Online discussions on detection and identification, in-
cluding unintentional transboundary movement and 
sampling, detection and identification of LMOs
• Open Ended Online Forum and AHTEG on Risk 
Assessment and Risk Management of LMOs
• Open-ended online forum on the issue of synthetic 
biology 
• Online discussions for the FAO-CBD-OECD on databases 
For more updates, please review the bi-annual reports at 
https://www.cbd.int/secretariat/qr/default.shtml
New Tools - Programme of Work on PAEP
Aarhus Convention/CBD Checklist 
and Tools Document
National Communication Plan Template
http://bch.cbd.int/onlineconferences/portal_art23/
pa_main.shtml
NBSAPs Forum on Biosafety 
Mainstream Biosafety into National Biodiversity 
Strategies and Action Plans, please join us.
http://nbsapforum.net/#categories/340
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SECTION II/ USEFUL INFORMATION
Statistics
Implementation of Liability and Redress 
(Operational objectives 1.5 and 2.4)
Source: National reports at http://bch.cbd.int/database/reports/
Domestic regulatory frameworks Capacity-building needs
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Recent and Upcoming Biosafety Events 
Events related to the Strategic Plan for the Protocol
COP-MOP 7
In its decision BS-VII/3, the Conference of the Parties serving 
as the meeting of the Parties to the Cartagena Protocol on 
Biosafety (COP-MOP) decided to undertake, at its 8th meeting, 
the third assessment and review of the effectiveness of the 
Protocol and the mid-term evaluation of the Strategic Plan for 
the Cartagena Protocol on Biosafety for the period 2011-2020, 
drawing upon information from the 3rd national reports as a 
primary source, the BCH and, where appropriate, additional 
data collected through dedicated surveys.
In the same decision, COP-MOP requested the relevant sub-
sidiary body (i.e. the Subsidiary Body on Implementation) en-
trusted with the task of reviewing the implementation of the 
Protocol, including contributions from the Liaison Group on 
Capacity-Building and input from the Compliance Committee. 
Capacity-building 
In response to the above decision, the 11th meeting of the 
Liaison Group on Capacity-building for Biosafety was convened, 
in Montreal, from 14 to 16 March 2016, to review the analysis of 
the status and trends in the implementation of the Protocol pre-
pared by the Secretary and considered general conclusions and 
recommendations to the Subsidiary Body on Implementation 
(when and where)
The Liaision group discussed the status and trends in imple-
menting the Protocol and decided on some draft conclusions 
and suggestions on the possible way forward. 
Compliance Committee
The 12th Committee Committee meeting (where and when) dis-
cussed the COP-MOP 7 decision, BS-VII/3, and agreed on the scope 
of the input it would provide into the 3rd assessment and review 
of the Protocol and the mid-term evaluation of the Strategic 
Plan, taking into account the role of the Liaison group on ca-
pacity-building and the Subsidiary Body on Implementation. 
The Committee agreed on the focus of its input.
The 13th Compliance Committee meeting, 13-15 May 2015, 
in Montreal, evaluated the status of implementation of the 
Protocol in meeting its objectives.
To assist the Committee provided an analysis of information 
from third national reports and presented findings against 
the baseline established in the context of the second assess-
ment and review completed by COP-MOP at its 6th meeting and 
through a survey on the Strategic Plan carried out after the 6th 
meeting to gather information corresponding to indicators in 
the Strategic Plan that could not be obtained from the second 
national reports or through other existing mechanisms. 
The Compliance Committee is preparing a report, including rec-
ommendations, for submission to COP-MOP 8. 
The Biosafety Clearing-House
The Secretariat has developed an analyser tool which allows the 
responses provided by Parties in their third national reports to 
be compared with the responses provided by the same Parties in 
their second national reports and the survey. The analyser tool 
is available at http://bch.cbd.int/database/reports/
The 12th Committee Committee meetingThe 11th meeting of the Liaison Group on Capacity-building for Biosafety
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Mainstreaming Biosafety
The Secretariat has held six workshops on mainstreaming bio-
safety into National Biodiversity Strategies and Action Plans and 
Resource Mobilization since 2014. The overall objective of the 
workshops was to strengthen the capacity of Parties in the re-
spective regions to integrate biosafety into NBSAPs and national 
development plans and mobilize resources for the implementation 
of the Protocol in line with the Strategic Plan for the Protocol 
and the relevant Aichi Biodiversity Targets. They also aimed to im-
prove understanding of the Nagoya-Kuala Lumpur Supplementary 
Protocol on Liability and Redress. 
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Other Meetings
• Tenth meeting of the Informal Advisory Committee on the 
Biosafety Clearing-House, 11 - 12 April 2016, Ispra, Italy
• Meeting of the Ad Hoc Technical Expert Group on Risk 
Assessment and Risk Management, 16 - 20 November 2015, 
in Brasilia, Brazil and 2 - 6 June 2014, in Bonn, Germany
• Meeting of the Ad Hoc Technical Expert Group on Synthetic 
Biology, 21 - 25 September 2015, in Montreal, Canada
• Workshop of the Network of Laboratories for the Detection 
and Identification of Living Modified Organisms, 9 - 11 June 
2015, in Ispra, Italy
• Ninth meeting of the Informal Advisory Committee on the 
Biosafety Clearing-House, 2 - 4 April 2014, in Ispra, Italy
• Ad Hoc Technical Expert Group Meeting on Socio-economic 
Considerations, 17 - 21 February 2014, in Seoul, Republic 
of Korea
• Round table on access to information, public participation 
and access to justice regarding LMOs/GMOs, 16 - 17 October 
2013, in Geneva, Switzerland
Survey results from the Roundtable are available at:
http://www.unece.org/index.php?id=31702#/
• 
Group meetings at the AHTEG meeting on Socio-economic Considerations
Co-Chairs at the AHTEG meeting on Socio-economic Considerations
From right: SCBD: Kathryn Garforth and 
Co-Chairs: Mr. Andreas Heissenberger from Austria and Ms. Ranjini Warrier from India
Left standing: Chair: Mr. Joachim Kreysa of the tenth meeting of 
the Informal Advisory Committee on the Biosafety Clearing-House 
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Upcoming Meetings
• Tenth meeting of the Informal Advisory Committee on the 
Biosafety Clearing-House, 11 April 2016 - 12 April 2016, in 
Ispra, Italy
• Ad Hoc Technical Expert Group on Risk Assessment and 
Risk Management, 25 July 2016 - 29 July 2016, in Mexico 
City, Mexico
• First meeting of the Subsidiary Body on Implementation 
(SBI 1), 2 - 6 May 2016, in Montreal, Canada
• Second round table on access to information, public par-
ticipation and access to justice regarding LMOs/GMOs, 
15-17 November 2016, in Geneva, Switzerland
• Eighth meeting of the Conference of the Parties serving 
as the meeting of the Parties to the Cartagena Protocol 
on Biosafety (COP-MOP8), 4 December 2016 - 17 December 
2016, in Cancun, Mexico
Other Upcoming Events
• COP-MOP 8 Fair in collaboration with the CEPA COP 13 Fair 
• International Day for Biodiversity, 22 May 2016, on 
Mainstreaming Biodiversity; Sustaining People and their 
Livelihoods. Review information at https://www.cbd.int/
idb/2016/ and submit any relevant biosafety messages by 
1 May 2016 to ulrika.nilsson@cbd.int 
• Annual exhibition at the Redpath Museum, McGill 
University, to  promote biosafety and sustainable devel-
opment, 29 May 2016
636 subscripers to the newsletter, please join at: 
https://bch.cbd.int/member/subscriptions.shtml
Other non-SCBD Meetings and Events
-The 11th Session of the Commission on Phytosanitary Mea-
sures (CPM - 11), 4 to 8 April 2016, in Rome, Italy
-OECD Working Group on the Harmonisation of Regula-
tory Oversight in Biotechnology, 13-15 April, 2016, in Paris, 
France   
-International Mother Earth Day, 22 April
-83rd General Session of the World Assembly of OIE Del-
egates, 24-29 May 2015, in Paris, France 
-Second meeting of the UN Environment Assembly, 23 – 27 
May 2016, in Nairobi, Kenya  
-Symposium on EuroAsian Biodiversity, 23 – 27 May 2016, in 
Antalya-Turkiye
-8th Trondheim Conference on Biodiversity, 30 May-3 June 
2016 , in Trondheim, Norway 
-154th Session of FAO Council, 30 May-1 June 2016, in Rome, 
Italy 
-World Environment Day, 5 June 2016
-2nd International Conference on Food Safety and Regulatory 
Measures, 6-8 June 2016, in London, UK 
-50TH GEF Council, 6-9 June 2016, in Washington  DC 
-International Conference on Plant Physiology & Pathology, 
9-10 June 2016, in Dallas, USA 
-Committee on Sanitary and Phytosanitary Measures, 6- 7 July 
2016, in Rome, Italy 
-High Level Political Forum on Sustainable Development 
(under ECOSOC), 11-20 July, 2016, in New York, USA  
-International Youth Day, 12 Auguest 2016
-7th International Crop Science Congress, 14-19 August 2016, 
in Beijing, China 
-United Nations Day for South-South Cooperation, 12 Septem-
ber 2016
-4th Annual  South Asia Biosafety Conference, 19-21 Septem-
ber 2016, in Hyderabad, India  
-25th Session FAO Committee on Agriculture (COAG), 26-30 
September 2016, in Rome, Italy 
-R-Biopharm: Workshop on Detection of pathogens and 
genetically modified organisms; detection of animal species, 
26-28 September 2016, real-time
-World Bank Annual Meeting, 7-9 October 2016, in Washing-
ton, D.C.  
-International Day of Rural Women, 15 October 2016 
-World Food Day, 16 October 2016
-43rd Session FAO Committee on World Food Security, 17-22 
October, 2016, in Rome, Italy 
-United Nations Day, 24 October 2016  
-103rd Session FAO Committee on Constitutional and Legal 
Matters, 24-26 October 2016, in Rome, Italy 
-51ST GEF Council, November 2016, in Washington D.C.  
Campaing to Join the IBD celebration 
The Cartagena Protocol on Biosafety to the Convention on Biological 
Diversity is an international agreement which aims to ensure the safe 
handling, transport and use of living modified organisms (LMOs) resulting 
from modern biotechnology that may have adverse effects on biological 
diversity, taking into account risks to human health.
The Nagoya - Kuala Lumpur Supplementary Protocol on Liability and 
Redress to the Cartagena Protocol on Biosafety is an international 
treaty which aims to contribute to the conservation and sustainable use 
of biodiversity by providing international rules and procedures for liability 
and redress in the event of damage resulting from LMOs.
OLIVIER LE MOAL/ISTOCKPHTO
